208 related articles for article (PubMed ID: 34809660)
1. Tumor cell invasion in blood vessels assessed by immunohistochemistry is related to decreased survival in patients with bladder cancer treated with radical cystectomy.
Carlsen B; Klingen TA; Andreassen BK; Haug ES
Diagn Pathol; 2021 Nov; 16(1):109. PubMed ID: 34809660
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical assessment of lymphatic and blood vessel invasion in T1 urothelial carcinoma of the bladder.
Gakis G; Todenhöfer T; Braun M; Fend F; Stenzl A; Perner S
Scand J Urol; 2015; 49(5):382-7. PubMed ID: 25921278
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of vascular invasion and standardization of its evaluation in stage I non-small cell lung cancer.
Hamanaka R; Yokose T; Sakuma Y; Tsuboi M; Ito H; Nakayama H; Yamada K; Masuda R; Iwazaki M
Diagn Pathol; 2015 Apr; 10():17. PubMed ID: 25884820
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of immunohistochemically detected blood and lymphatic vessel invasion in colorectal carcinoma: its impact on prognosis.
Liang P; Nakada I; Hong JW; Tabuchi T; Motohashi G; Takemura A; Nakachi T; Kasuga T; Tabuchi T
Ann Surg Oncol; 2007 Feb; 14(2):470-7. PubMed ID: 17103258
[TBL] [Abstract][Full Text] [Related]
5. Assessment of vascular invasion in gastric cancer: a comparative study.
Gresta LT; Rodrigues-Júnior IA; de Castro LP; Cassali GD; Cabral MM
World J Gastroenterol; 2013 Jun; 19(24):3761-9. PubMed ID: 23840114
[TBL] [Abstract][Full Text] [Related]
6. Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis.
Marinho VF; Metze K; Sanches FS; Rocha GF; Gobbi H
BMC Cancer; 2008 Feb; 8():64. PubMed ID: 18307818
[TBL] [Abstract][Full Text] [Related]
7. Distinguishing blood and lymph vessel invasion in breast cancer: a prospective immunohistochemical study.
Van den Eynden GG; Van der Auwera I; Van Laere SJ; Colpaert CG; van Dam P; Dirix LY; Vermeulen PB; Van Marck EA
Br J Cancer; 2006 Jun; 94(11):1643-9. PubMed ID: 16670715
[TBL] [Abstract][Full Text] [Related]
8. Objective assessment of lymphatic and blood vascular invasion in lymph node-negative breast carcinoma: findings from a large case series with long-term follow-up.
Mohammed RA; Martin SG; Mahmmod AM; Macmillan RD; Green AR; Paish EC; Ellis IO
J Pathol; 2011 Feb; 223(3):358-65. PubMed ID: 21171081
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of detecting lymphatic and blood vessel invasion in stage II colon cancer using markers D2-40 and CD34 in combination.
Lai JH; Zhou YJ; Bin D; Qiangchen ; Wang SY
Asian Pac J Cancer Prev; 2014; 15(3):1363-7. PubMed ID: 24606466
[TBL] [Abstract][Full Text] [Related]
10. The aggressiveness of urothelial carcinoma depends to a large extent on lymphovascular invasion--the prognostic contribution of related molecular markers.
Afonso J; Santos LL; Amaro T; Lobo F; Longatto-Filho A
Histopathology; 2009 Nov; 55(5):514-24. PubMed ID: 19912357
[TBL] [Abstract][Full Text] [Related]
11. [Detection of lymphovascular invasion in urothelial carcinoma of the bladder through D2-40 immunostaining].
Martini T; Ströbel P; Steidler A; Petrakopoulou N; Erben P; Bolenz C
Urologe A; 2015 Jan; 54(1):70-5. PubMed ID: 25391439
[TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy.
Lotan Y; Bagrodia A; Passoni N; Rachakonda V; Kapur P; Arriaga Y; Bolenz C; Margulis V; Raj GV; Sagalowsky AI; Shariat SF
Eur Urol; 2013 Sep; 64(3):465-71. PubMed ID: 23571005
[TBL] [Abstract][Full Text] [Related]
13. Improved methods of detection of lymphovascular invasion demonstrate that it is the predominant method of vascular invasion in breast cancer and has important clinical consequences.
Mohammed RA; Martin SG; Gill MS; Green AR; Paish EC; Ellis IO
Am J Surg Pathol; 2007 Dec; 31(12):1825-33. PubMed ID: 18043036
[TBL] [Abstract][Full Text] [Related]
14. Tumour cell invasion into blood vessels is significantly related to breast cancer subtypes and decreased survival.
Klingen TA; Chen Y; Stefansson IM; Knutsvik G; Collett K; Abrahamsen AL; Aase H; Aas H; Aas T; Wik E; Akslen LA
J Clin Pathol; 2017 Apr; 70(4):313-319. PubMed ID: 27612505
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated macrophages are strongly related to vascular invasion, non-luminal subtypes, and interval breast cancer.
Klingen TA; Chen Y; Aas H; Wik E; Akslen LA
Hum Pathol; 2017 Nov; 69():72-80. PubMed ID: 28923419
[TBL] [Abstract][Full Text] [Related]
16. Importance of tumour cell invasion in blood and lymphatic vasculature among patients with endometrial carcinoma.
Mannelqvist M; Stefansson I; Salvesen HB; Akslen LA
Histopathology; 2009 Jan; 54(2):174-83. PubMed ID: 19207942
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of lymphatic and blood vessel invasion in oral tongue squamous cell carcinomas.
Michikawa C; Uzawa N; Kayamori K; Sonoda I; Ohyama Y; Okada N; Yamaguchi A; Amagasa T
Oral Oncol; 2012 Apr; 48(4):320-4. PubMed ID: 22178206
[TBL] [Abstract][Full Text] [Related]
18. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
Lotan Y; Gupta A; Shariat SF; Palapattu GS; Vazina A; Karakiewicz PI; Bastian PJ; Rogers CG; Amiel G; Perotte P; Schoenberg MP; Lerner SP; Sagalowsky AI
J Clin Oncol; 2005 Sep; 23(27):6533-9. PubMed ID: 16116151
[TBL] [Abstract][Full Text] [Related]
19. Accuracy and prognostic value of variant histology and lymphovascular invasion at transurethral resection of bladder.
Abufaraj M; Shariat SF; Foerster B; Pozo C; Moschini M; D'Andrea D; Mathieu R; Susani M; Czech AK; Karakiewicz PI; Seebacher V
World J Urol; 2018 Feb; 36(2):231-240. PubMed ID: 29127452
[TBL] [Abstract][Full Text] [Related]
20. Detection of lymphovascular invasion by D2-40 (podoplanin) immunoexpression in endometrial cancer.
Weber SK; Sauerwald A; Pölcher M; Braun M; Debald M; Serce NB; Kuhn W; Brunagel-Walgenbach G; Rudlowski C
Int J Gynecol Cancer; 2012 Oct; 22(8):1442-8. PubMed ID: 22964524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
